StockData
Exelixis, Inc. logo

Exelixis, Inc. (EXEL) stock

EXELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends January 1
Financials through Q3 FY2026, quarter ended Oct 2, 2026Last filing: 10-Q on Oct 29, 2026Score 18/301% above fair value
$69.00−0.84 (-1.20%)

Close on Nov 13, 2026Market cap $16.84BP/E 20.7Yield –

Exelixis operating margin

Operating margin is operating income as a percentage of revenue.

Exelixis's operating margin for the twelve months ending Oct 2, 2026 was 40.2%. For fiscal 2025 it was 37.6%, against 27.9% the year before. The highest annual figure on record is 51.4% in fiscal 2018.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Jan 2, 202637.6%+9.7
FY2024Jan 3, 202527.9%+18.5
FY2023Dec 29, 20239.3%−3.2
FY2022Dec 30, 202212.5%−7.5
FY2021Dec 31, 202120.0%+8.8
FY2020Jan 1, 202111.1%−27.0
FY2019Jan 3, 202038.2%−13.2
FY2018Dec 28, 201851.4%+14.7
FY2017Dec 29, 201736.7%+51.4
FY2016Dec 31, 2016-14.7%+312.0
FY2015Dec 31, 2015-326.6%+567.2
FY2014Dec 31, 2014-893.9%−253.3
FY2013Dec 31, 2013-640.5%−382.5
FY2012Dec 31, 2012-258.0%−288.9
FY2011Dec 31, 201130.9%+80.3
FY2010Dec 31, 2010-49.4%+30.9
FY2009Dec 31, 2009-80.3%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Oct 2, 202640.8%+1.2
Q2 FY2026Jul 3, 202639.5%+1.9
Q1 FY2026Apr 3, 202641.1%+7.5
Q4 FY2025Jan 2, 202639.3%+10.5
Q3 FY2025Oct 3, 202539.6%+14.4
Q2 FY2025Jul 4, 202537.6%−5.7
Q1 FY2025Apr 4, 202533.6%+26.7
Q4 FY2024Jan 3, 202528.8%+11.7
Q3 FY2024Sep 27, 202425.2%+28.9
Q2 FY2024Jun 28, 202443.3%+26.7
Q1 FY2024Mar 29, 20246.9%−0.1
Q4 FY2023Dec 29, 202317.1%+28.4
Q3 FY2023Sep 29, 2023-3.7%−23.8
Q2 FY2023Jun 30, 202316.6%−3.4
Q1 FY2023Mar 31, 20237.1%−16.3
Q4 FY2022Dec 30, 2022-11.3%−37.2
Q3 FY2022Sep 30, 202220.1%+4.3
Q2 FY2022Jul 1, 202220.0%−12.0
Q1 FY2022Apr 1, 202223.4%+25.1
Q4 FY2021Dec 31, 202125.9%+16.9
Q3 FY2021Oct 1, 202115.7%+34.1
Q2 FY2021Jul 2, 202131.9%+2.8
Q1 FY2021Apr 2, 2021-1.7%−25.0
Q4 FY2020Jan 1, 20219.0%−23.2
Q3 FY2020Oct 2, 2020-18.4%−61.0
Q2 FY2020Jul 3, 202029.1%−9.2
Q1 FY2020Apr 3, 202023.3%−16.0
Q4 FY2019Jan 3, 202032.2%−16.6
Q3 FY2019Sep 27, 201942.5%−13.0
Q2 FY2019Jun 28, 201938.3%−7.8
Q1 FY2019Mar 29, 201939.2%−15.2
Q4 FY2018Dec 28, 201848.8%+17.6
Q3 FY2018Sep 28, 201855.5%+2.3
Q2 FY2018Jun 29, 201846.1%+18.7
Q1 FY2018Mar 30, 201854.4%+29.5
Q4 FY2017Dec 29, 201731.2%−18.9
Q3 FY2017Sep 30, 201753.2%–
Q2 FY2017Jun 30, 201727.4%–
Q1 FY2017Mar 31, 201725.0%–
Q4 FY2016Dec 31, 201650.1%–

More Exelixis figures

See a number that looks wrong?